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We have demonstrated the detection of alpha-fetoprotein (AFP) labeled with magnetic nanoparticles
(MNPs) using MgO-based magnetic tunnel junction (MTJ) sensors. AFP is an important hepatic
tumor biomarker and the detection of AFP has significant applications for clinical diagnostics and
immunoassay for early-stage liver cancer indications. In this work, MgO-based MTJ sensors and
20-nm iron-oxide magnetic nanoparticles (MNPs) were used for detecting AFP antigens by a
sandwich-assay configuration. The MTJ sensors with a sensing area of 4 2lm2 possess tunneling
magnetoresistance (TMR) of 122% and sensitivity of 0.95%/Oe at room temperature. The target AFP
antigens of three concentrations were successfully detected, and the experimental data indicate that
the resistance variations of the MTJ sensor increased with the AFP concentration ratios
proportionally. These results demonstrate that MgO-based MTJ sensors together with MNPs are a
promising biosensing platform for liver cancer immunoassay.VC 2012 American Institute of Physics.
[doi:10.1063/1.3676212]
I. INTRODUCTION
Liver cancer immunoassay has long been studied because
of the poor survival rate of cancerous patients and the lack of
effective methods for cancer treatments. Early-stage detection
of hepatocellular carcinoma (HCC) benefits cancer patients
with asymptomatic hepatitis by helping them avoid surgical
resection or liver transplantation. Currently, cancer immuno-
assay is dominated by fluoroimmunoassay (FIA), enzyme im-
munoassay (EIA), and radioimmunoassay (RIA) technology.
However, these diagnostic methods are confronted with disad-
vantages, such as high cost, they are time-consuming, and
there are hazards for handling the radioactive antigen.1 An al-
ternative approach for bioanalytical assay is magnetic immu-
noassay (MIA), which utilizes ultra-sensitive spintronic
magnetometer as a biosensor to detect the biomolecules la-
beled with functionalized magnetic nanoparticles (MNPs). In
biodetections, the dimension of MNPs is comparable to bio-
molecules and thus capable of realizing single binding with
the analytes. The presence of analytes can be identified by the
magnetic field emanated from the binding MNPs, and the field
intensity can be subsequently measured by the ultra-sensitive
magnetometer. This MIA assay method takes advantage of
high-sensitivity, low-cost, and portable capabilities of spin-
tronic sensors.
Magnetic tunnel junctions (MTJs) are recognized as an
ideal sensor element for biosensors and biochips because of
their high tunneling magnetoresistance (TMR) ratios, small
size, low cost, and lab-on-chip compatibility.2–5 MgO-based
MTJs experimentally demonstrated TMR ratio of 604% at
room temperature,6 and picotesla-sensitivity MTJ sensors are
under intensive research.7,8 The sensing platform of MTJ sen-
sors together with MNPs has successfully been applied for
detecting protein binding and DNA hybridization in previous
studies.2,4,9 In this work, we demonstrate the feasibility of
detecting alpha-fetoprotein (AFP) tagged with 20-nm mono-
disperse iron-oxide MNPs using MgO-based MTJ sensors.
Because the carriers of hepatitis B and C viruses suffer a high
risk of developing HCC and AFP as a crucial hepatic tumor
biomarker, it is very useful for early-stage liver cancer indica-
tions, and the biodetection of AFP will bring a revolutionary
impact to clinical diagnostics and immunoassay for HCC
biorecognition.1,9,10
II. EXPERIMENT
The MTJ stack (purchased from Micro Magnetics) was
deposited on thermally oxidized silicon wafers by a magne-
tron sputtering system with a base pressure of 2 108 Torr,
and it is composed of the following structure (units in nano-
meters): substrate/Ta (5)/Ru (30)/Ta (5)/CoFe (2)/IrMn (15)/
CoFe (2)/Ru (0.8)/CoFeB (3)/MgO (1.9)/CoFeB (3)/Ta (5)/
Ru (10). The sensing area of the MTJ junctions is 4 2 lm2
and the junctions were patterned with optical lithography
and ion milling. A layer of gold with a thickness of 200 nm
was deposited on top of the MTJs and serves as botha)Electronic mail: ppong@eee.hku.hk.
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electrical contacts as well as a biologically active area. This
biologically active interface can provide a platform for selec-
tively immobilizing anti-AFP antibodies onto the sensing
area of MTJs. The TMR transfer curve was characterized
with a standard four-probe method. Both the MTJ sensors
and the sample stage were shielded in a mu-metal shielding
box to exempt them from the disturbances of an ambient
magnetic field. The easy-axis and hard-axis magnetic fields
were provided by a pair of Helmholtz coils and all the meas-
urements were carried out at room temperature.
Prior to the AFP-MIA experiment, MTJ sensors and
MNPs need to be biologically treated. Monoclonal anti-
AFP antibodies from human cord blood (purchased from
Fitzgerald Industries International) were immobilized onto
the biologically active surface of the MTJ sensor to be the
capturing anti-AFPs for capturing the target AFP antigens.
After the incubation, blocking solution (5.00% Skim Milk
in phosphate-buffered saline with 0.05% TWEEN-20) was
introduced to reduce undesirable non-specific binding of
protein molecules onto the MTJ sensor surface, which
might induce false results.11 Iron-oxide MNPs (Fe3O4, pur-
chased from Ocean Nanotech) with carboxyl groups were
used for biomagnetically labeling the detecting anti-AFPs
because of their high magnetization and biocompatibility.12
The surfaces of the MNPs were coated with carboxylic acid
groups for the purpose of functionalizing the MNPs with
exterior modification, so that the MNPs are capable of
binding with the detecting anti-AFP antibodies. The bio-
functionalized MNPs were prepared with a constant con-
centration of 1.00mg/ml. Figure 1 depicts the vibrating
sample magnetometry (VSM) measurement result of these
MNPs in the solvent of de-ionized (DI) water. The MNPs
exhibit superparamagnetism and they possess a magnetiza-
tion of 50 emu/g.
After the biofunctionalizations of the MgO-MTJ sensors
with capturing anti-AFP antibodies and the MNPs with detect-
ing anti-AFP antibodies, the detection of target AFP antigens
was carried out with a sandwich-assay configuration, which is
schematically shown in Fig. 2. The monodisperse MNPs
conjugated with the detecting anti-AFPs possess a diameter of
20 nm and exhibit no aggregation as shown in the TEM image
(inset of Fig. 2). The antibody-functionalized MTJ sensor
surface was initially covered with target AFP antigens and
washed with phosphate-buffered saline with 0.05% TWEEN-
20 (PBST) after the full binding of the target AFP antigens to
the capturing anti-AFP antibodies attached to the MTJ sensor
surface. Subsequently, the MNPs conjugated with the detect-
ing anti-AFP antibodies were introduced, and the capturing
and detecting anti-AFPs bound to the target AFP antigens at
the different epitopes. Magnetotransport characterization was
performed on the MTJ sensor after flushing the sensor surface
with PBST solution for removing excess MNPs.
III. RESULTS AND DISCUSSION
The target AFP antigens with three different concentra-
tions of 0.002, 0.010, and 0.050mg/ml were successively
detected by the same MgO-MTJ sensor. A hard-axis field of
60Oe was applied for polarizing and magnetizing the MNPs.
Compared to other biasing modes, this in-plane dc magnetic
field is also effective for reducing the hysteresis as well as
sensor magnetic noise by stabilizing the magnetic layers in
MTJs.13–15 The TMR transfer curves of MTJ sensors were
measured before and after the binding of biofunctionalized
MNPs. Figure 3 presents the TMR transfer curve of MgO-
based MTJ sensor without any MNP binding. The MTJ sen-
sors exhibited TMR ratio of 122% and sensitivity of 0.95%/
Oe. The inset is an optical image of the MTJ sensing area.
This sensitivity is compared with the MTJ biosensors used
FIG. 1. VSM measurement showing the magnetic moment as a function of
applied magnetic field. The samples of the iron-oxide MNPs with carboxyl
groups were measured in the solvent of DI water. The saturation magnetiza-
tion is 50 emu/g.
FIG. 2. (Color online) Schematic drawings of AFP detection with a
sandwich-assay configuration. The MgO-based MTJ sensor surface is
bonded with the capturing anti-AFP antibodies, and the carboxylated MNPs
are covalently coupled to the detecting anti-AFP antibodies. The target AFP
antigens can conjugate with both the capturing and detecting anti-AFP anti-
bodies at different epitopes. The inset TEM image shows the monodisperse
biofunctionalized MNPs. The isotropic MNPs possess a diameter of 20 nm.
FIG. 3. (Color online) TMR transfer curve of the MTJ sensor. The sensor
exhibits a TMR ratio 122% and a sensitivity of 0.95%/Oe under 60-Oe hard-
axis biasing field. The inset shows the optical image of the MTJ sensor.
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previously in other groups. Cardoso et al.3 obtained a sensi-
tivity of 0.73%/Oe with the Al2O3-barrier MTJ-biochips.
Shen et al. applied the arrays of MgO-MTJ with sensitivities
of 0.91%/Oe (Ref. 4) and 1.00%/Oe (Ref. 5) for detecting
DNA labeled with MNPs. Compared with these results, the
MTJ sensors in this work exhibited a reasonably high sensi-
tivity for biodetection. The resistance of the MTJ sensor
changed with the concentration of the target AFP antigens,
and the relation of resistance variations DR against easy-axis
fields is shown in Fig. 4. Piranha solution was employed to
effectively clean the sensor surface before a new experiment.
To guarantee that there are no residual binding MNPs after
the washing out, a reference measurement was carried out,
and it is plotted in Fig. 4 as well. The maximum DR after
binding the MNPs are 17, 143, and 271 X, respectively, for
the target AFP antigen concentrations of 0.002, 0.010, and
0.050mg/ml. Because the concentration of MNPs conjugated
with anti-AFP remained the same in these three measure-
ments, the variations of DR corresponding to the different tar-
get AFP antigen concentrations can be attributed to the
different number of biomolecular binding events between the
target AFPs and the detecting anti-AFPs. Figure 5 illustrates
the relation between maximum DR and the concentrations of
target AFP antigens. The error bars represent the standard
deviations for the DR between 406 10Oe, where the MTJ
sensor exhibits the maximum DR. We can observe that the re-
sistance of MgO-based MTJ sensors is sensitive to the MNPs
and the maximum DR changes logarithmically with the
increase of AFP concentrations. Consequently, the AFP anti-
gen concentration can be deduced through the DR of MTJ
sensors. This logarithm relation consists of the previous
works reported for detecting MNPs15 and DNA4,16 using
other MR sensors. The AFP concentration of 0.010mg/ml is
recognized as the threshold of screening tests for HCC in
patients with chronic hepatitis C.17 The demonstration of
AFP detection at this and even lower concentration levels in
this work indicates that this biosensing platform of MgO-
based MTJ sensors and MNPs is capable of liver cancer im-
munoassay for clinical applications.
IV. CONCLUSIONS
In summary, we have demonstrated the feasibility of
liver cancer immunoassay with MNPs and MgO-based MTJ
sensors by a sandwich-assay configuration, in which both
detecting and capturing anti-AFP antibodies were employed
for detecting the target AFP antigens. The MTJ sensors and
Fe3O4 MNPs were biologically treated before the AFP-MIA
experiment. The detection of target AFP antigens caused an
increase of resistance variations of the same MTJ sensor in
proportion to the logarithm of the AFP antigen concentra-
tion. This logarithm relation can be applied for identifying
the presence of target AFPs and further deducing their
concentrations.
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FIG. 4. (Color online) Diagram of the MTJ sensor resistance variations DR
after binding with three different concentrations of target AFP antigens. The
maximum resistance deviations appear at approximately 40Oe, with the
maximums of 17, 143, and 271 X, respectively.
FIG. 5. (Color online) Plot of maximum DR vs AFP antigen concentration.
The error bars represent the standard deviations for the DR between 30Oe
and 50Oe. The fitting curve (solid line) illustrates that DR changes logarith-
mically with the concentration of target AFP antigens.
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